- Home
- SDGR vs NBXG Comparison
SDGR vs NBXG Comparison
Compare SDGR & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDGR | NBXG |
|---|---|---|
| Founded | 1990 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SDGR | NBXG |
|---|---|---|
| Price | $14.90 | $14.41 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | ★ 960.8K | 243.7K |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $256,951,000.00 | N/A |
| Revenue This Year | $23.69 | N/A |
| Revenue Next Year | $20.32 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.90 | N/A |
| 52 Week Low | $15.52 | $9.31 |
| 52 Week High | $28.47 | $12.23 |
Technical Indicators
Market Signals| Indicator | SDGR | NBXG |
|---|---|---|
| Relative Strength Index (RSI) | 29.52 | 45.60 |
| Support Level | $16.07 | $14.30 |
| Resistance Level | $17.87 | $14.40 |
| Average True Range (ATR) | 0.78 | 0.17 |
| MACD | -0.31 | -0.03 |
| Stochastic Oscillator | 2.11 | 36.14 |
Price Performance
Historical ComparisonAbout SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".